glp 1 drugs and anxiety Beyond the scale: How GLP-1 medications are affecting both body mind GLP-1 diabetes drugs could stop

doi: 10.1111/os.13606 10 BensonJCMaraisMDFlaniganPMBydonMGianniniCSpinnerRJet al

a - f , Treatment of C57BL/6 J DIO mice with once-daily subcutaneous (s.c.) injections of 900 nmol kg 1 MK-801 (n = 8 mice and n = 4 cages), 1800 nmol kg 1 MK-801 (n = 6 mice and n = 3 cages) or vehicle (isotonic saline, n = 7 mice and n = 3 cages) over 7 days

10.1186/1743-7075-10-28 15 KimB

doi: 10.1016/0960-9822(93)90001-5 340 ViguL.Eyre-WalkerA

Each lot of AOD 9604 is independently tested

These results confirm the previously suspected association between sertraline treatment and lipid storage myopathy and provide morphological and biochemical characteristics in this disease